decoquinate has been researched along with Malaria, Falciparum in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clardy, J; Derbyshire, ER; Mota, MM; PrudĂȘncio, M | 1 |
Hickman, M; Kozar, MP; Lee, PJ; Li, Q; Melendez, V; Reyes, S; Roncal, N; Wang, H; Xie, L; Zeng, Q; Zhang, J; Zhang, P | 1 |
2 other study(ies) available for decoquinate and Malaria, Falciparum
Article | Year |
---|---|
Liver-stage malaria parasites vulnerable to diverse chemical scaffolds.
Topics: Animals; Anopheles; Antimalarials; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Inhibitory Concentration 50; Insect Vectors; Life Cycle Stages; Liver; Malaria; Malaria, Falciparum; Male; Mice; Mice, Inbred C57BL; Plasmodium berghei; Plasmodium falciparum; Treatment Outcome | 2012 |
Nanoparticle formulations of decoquinate increase antimalarial efficacy against liver stage Plasmodium infections in mice.
Topics: Administration, Oral; Animals; Antimalarials; Decoquinate; Humans; Liver; Malaria, Falciparum; Mice; Nanoparticles; Plasmodium berghei | 2014 |